Cargando…

Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target

Natural killer (NK) cells are key effectors of the innate immune system, but major differences between human and murine NK cells have impeded translation. Outbred dogs offer an important link for studies of NK biology and immunotherapy. We analyzed gene expression of putative NK populations from hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Gingrich, Alicia A., Reiter, Taylor E., Judge, Sean J., York, Daniel, Yanagisawa, Mio, Razmara, Aryana, Sturgill, Ian, Basmaci, Ugur Nur, Brady, Rachel V., Stoffel, Kevin, Murphy, William J., Rebhun, Robert B., Brown, C. Titus, Canter, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476892/
https://www.ncbi.nlm.nih.gov/pubmed/34594320
http://dx.doi.org/10.3389/fimmu.2021.670309
_version_ 1784575718642941952
author Gingrich, Alicia A.
Reiter, Taylor E.
Judge, Sean J.
York, Daniel
Yanagisawa, Mio
Razmara, Aryana
Sturgill, Ian
Basmaci, Ugur Nur
Brady, Rachel V.
Stoffel, Kevin
Murphy, William J.
Rebhun, Robert B.
Brown, C. Titus
Canter, Robert J.
author_facet Gingrich, Alicia A.
Reiter, Taylor E.
Judge, Sean J.
York, Daniel
Yanagisawa, Mio
Razmara, Aryana
Sturgill, Ian
Basmaci, Ugur Nur
Brady, Rachel V.
Stoffel, Kevin
Murphy, William J.
Rebhun, Robert B.
Brown, C. Titus
Canter, Robert J.
author_sort Gingrich, Alicia A.
collection PubMed
description Natural killer (NK) cells are key effectors of the innate immune system, but major differences between human and murine NK cells have impeded translation. Outbred dogs offer an important link for studies of NK biology and immunotherapy. We analyzed gene expression of putative NK populations from healthy dogs and dogs with naturally-occurring cancers examining differential gene expression across multiple conditions, including steady-state, in vitro activation with cytokines and co-culture, and in vivo activation with inhaled IL-15 in dogs receiving IL-15 immunotherapy. We also compared dog, mouse and human CD3-NKp46+ NK cells using a novel orthologous transcriptome. Distinct transcriptional profiles between NK populations exist between conditions and in vitro versus in vivo treatments. In cross-species analysis, canine NK cells were globally more similar to human NK cells than mice. These data define canine NK cell gene expression under multiple conditions and across species, filling an important gap in translational NK studies.
format Online
Article
Text
id pubmed-8476892
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84768922021-09-29 Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target Gingrich, Alicia A. Reiter, Taylor E. Judge, Sean J. York, Daniel Yanagisawa, Mio Razmara, Aryana Sturgill, Ian Basmaci, Ugur Nur Brady, Rachel V. Stoffel, Kevin Murphy, William J. Rebhun, Robert B. Brown, C. Titus Canter, Robert J. Front Immunol Immunology Natural killer (NK) cells are key effectors of the innate immune system, but major differences between human and murine NK cells have impeded translation. Outbred dogs offer an important link for studies of NK biology and immunotherapy. We analyzed gene expression of putative NK populations from healthy dogs and dogs with naturally-occurring cancers examining differential gene expression across multiple conditions, including steady-state, in vitro activation with cytokines and co-culture, and in vivo activation with inhaled IL-15 in dogs receiving IL-15 immunotherapy. We also compared dog, mouse and human CD3-NKp46+ NK cells using a novel orthologous transcriptome. Distinct transcriptional profiles between NK populations exist between conditions and in vitro versus in vivo treatments. In cross-species analysis, canine NK cells were globally more similar to human NK cells than mice. These data define canine NK cell gene expression under multiple conditions and across species, filling an important gap in translational NK studies. Frontiers Media S.A. 2021-09-14 /pmc/articles/PMC8476892/ /pubmed/34594320 http://dx.doi.org/10.3389/fimmu.2021.670309 Text en Copyright © 2021 Gingrich, Reiter, Judge, York, Yanagisawa, Razmara, Sturgill, Basmaci, Brady, Stoffel, Murphy, Rebhun, Brown and Canter https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Gingrich, Alicia A.
Reiter, Taylor E.
Judge, Sean J.
York, Daniel
Yanagisawa, Mio
Razmara, Aryana
Sturgill, Ian
Basmaci, Ugur Nur
Brady, Rachel V.
Stoffel, Kevin
Murphy, William J.
Rebhun, Robert B.
Brown, C. Titus
Canter, Robert J.
Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target
title Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target
title_full Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target
title_fullStr Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target
title_full_unstemmed Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target
title_short Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target
title_sort comparative immunogenomics of canine natural killer cells as immunotherapy target
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476892/
https://www.ncbi.nlm.nih.gov/pubmed/34594320
http://dx.doi.org/10.3389/fimmu.2021.670309
work_keys_str_mv AT gingrichaliciaa comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget
AT reitertaylore comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget
AT judgeseanj comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget
AT yorkdaniel comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget
AT yanagisawamio comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget
AT razmaraaryana comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget
AT sturgillian comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget
AT basmaciugurnur comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget
AT bradyrachelv comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget
AT stoffelkevin comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget
AT murphywilliamj comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget
AT rebhunrobertb comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget
AT brownctitus comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget
AT canterrobertj comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget